128 related articles for article (PubMed ID: 36941225)
21. Hypoalbuminemia for the prediction of venous thromboembolism and treatment of direct oral anticoagulants in metastatic gastric cancer patients.
Takayoshi K; Kusaba H; Aikawa T; Koreishi S; Sagara K; Nakano M; Komoda M; Kono M; Fukata M; Arita T; Esaki T; Akashi K; Baba E
Gastric Cancer; 2019 Sep; 22(5):988-998. PubMed ID: 30788749
[TBL] [Abstract][Full Text] [Related]
22. Investigation of two general venous thromboembolism risk-stratification models in predicting venous thromboembolic events in TB patients.
Sharif-Kashani B; Azimi M; Tabarsi P; Sadr M; Shirzadi S
Int J Mycobacteriol; 2022; 11(1):83-87. PubMed ID: 35295028
[TBL] [Abstract][Full Text] [Related]
23. Risk and timing of venous thromboembolism in patients with gastrointestinal cancer: a nationwide Danish cohort study.
Tønnesen J; Pallisgaard J; Rasmussen PV; Ruwald MH; Lamberts M; Nouhravesh N; Strange J; Gislason GH; Hansen ML
BMJ Open; 2023 Jan; 13(1):e062768. PubMed ID: 36657765
[TBL] [Abstract][Full Text] [Related]
24. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States.
Khorana AA; Dalal M; Lin J; Connolly GC
Cancer; 2013 Feb; 119(3):648-55. PubMed ID: 22893596
[TBL] [Abstract][Full Text] [Related]
25. Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors.
Alma S; Eloi D; Léa V; Julie C; Valérie M; Pierre G; Hilgers W; Philippe G; Christine Z; Philippe D
J Thromb Thrombolysis; 2022 Aug; 54(2):287-294. PubMed ID: 35396660
[TBL] [Abstract][Full Text] [Related]
26. Venous thromboembolism prophylaxis during neoadjuvant therapy for resectable and borderline resectable pancreatic cancer-Is it indicated?
Krepline AN; Christians KK; George B; Ritch PS; Erickson BA; Tolat P; Evans DB; Tsai S
J Surg Oncol; 2016 Oct; 114(5):581-586. PubMed ID: 27760280
[TBL] [Abstract][Full Text] [Related]
27. Early venous thromboembolism at the beginning of palliative chemotherapy is a poor prognostic factor in patients with metastatic pancreatic cancer: a retrospective study.
Kim JS; Kang EJ; Kim DS; Choi YJ; Lee SY; Kim HJ; Seo HY; Kim JS
BMC Cancer; 2018 Dec; 18(1):1260. PubMed ID: 30558603
[TBL] [Abstract][Full Text] [Related]
28. The impact of thromboprophylaxis with LMWHs on the survival of patients with pancreatic cancer.
Sarantis P; Karamouzis MV
Thromb Res; 2022 May; 213 Suppl 1():S120-S126. PubMed ID: 36210553
[TBL] [Abstract][Full Text] [Related]
29. The short- and long-term risk of venous thromboembolism in patients with acute spinal cord injury: a prospective cohort study.
Giorgi Pierfranceschi M; Donadini MP; Dentali F; Ageno W; Marazzi M; Bocchi R; Imberti D
Thromb Haemost; 2013 Jan; 109(1):34-8. PubMed ID: 23223906
[TBL] [Abstract][Full Text] [Related]
30. The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis.
Zhang C; Zhang Z; Mi J; Wang X; Zou Y; Chen X; Nie Z; Luo X; Gan R
Medicine (Baltimore); 2019 Jun; 98(23):e15833. PubMed ID: 31169685
[TBL] [Abstract][Full Text] [Related]
31. Extended postoperative thromboprophylaxis after pancreatic resection for pancreatic cancer is associated with decreased risk of venous thromboembolism in the minimally invasive approach.
Sood D; Kuchta K; Paterakos P; Schwarz JL; Rojas A; Choi SH; Vining CC; Talamonti MS; Hogg ME
J Surg Oncol; 2023 Mar; 127(3):413-425. PubMed ID: 36367398
[TBL] [Abstract][Full Text] [Related]
32. Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk?
White RH; Chew H; Wun T
Thromb Res; 2007; 120 Suppl 2():S29-40. PubMed ID: 18023711
[TBL] [Abstract][Full Text] [Related]
33. Outcomes following pancreatic surgery using three different thromboprophylaxis regimens.
Hanna-Sawires RG; Groen JV; Klok FA; Tollenaar RAEM; Mesker WE; Swijnenburg RJ; Vahrmeijer AL; Bonsing BA; Mieog JSD
Br J Surg; 2019 May; 106(6):765-773. PubMed ID: 30776085
[TBL] [Abstract][Full Text] [Related]
34. Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients.
Mandalà M; Reni M; Cascinu S; Barni S; Floriani I; Cereda S; Berardi R; Mosconi S; Torri V; Labianca R
Ann Oncol; 2007 Oct; 18(10):1660-5. PubMed ID: 17660490
[TBL] [Abstract][Full Text] [Related]
35. Incidence and risk factors of symptomatic venous thromboembolism related to implanted ports in cancer patients.
Piran S; Ngo V; McDiarmid S; Le Gal G; Petrcich W; Carrier M
Thromb Res; 2014 Jan; 133(1):30-3. PubMed ID: 24188799
[TBL] [Abstract][Full Text] [Related]
36. Venous Thromboembolism Among Hospitalized Patients: Incidence and Adequacy of Thromboprophylaxis - A Retrospective Study.
Ambra N; Mohammad OH; Naushad VA; Purayil NK; Mohamedali MG; Elzouki AN; Khalid MK; Illahi MN; Palol A; Barman M; Sharif M; Chalihadan S; Punnorath A; Mostafa A; Al Hariri B; Khidir TGM; Varikkodan I
Vasc Health Risk Manag; 2022; 18():575-587. PubMed ID: 35912018
[TBL] [Abstract][Full Text] [Related]
37. Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population.
Mahan CE; Fisher MD; Mills RM; Fields LE; Stephenson JJ; Fu AC; Spyropoulos AC
Thromb Res; 2013 Nov; 132(5):520-6. PubMed ID: 24080150
[TBL] [Abstract][Full Text] [Related]
38. Venous thromboembolism risk factors in Chinese non-small cell lung cancer patients.
Wang Z; Yan HH; Yang JJ; Wang BC; Chen HJ; Zhou Q; Xu CR; Jiang BY; Wu YL
Support Care Cancer; 2015 Mar; 23(3):635-41. PubMed ID: 25155313
[TBL] [Abstract][Full Text] [Related]
39. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
[TBL] [Abstract][Full Text] [Related]
40. Cancer-related venous thromboembolism: insight into underestimated risk factors.
Al Diab AI
Hematol Oncol Stem Cell Ther; 2010; 3(4):191-5. PubMed ID: 21150239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
